Correlation Between Reata Pharmaceuticals and Biovie

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Reata Pharmaceuticals and Biovie at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Reata Pharmaceuticals and Biovie into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Reata Pharmaceuticals and Biovie Inc, you can compare the effects of market volatilities on Reata Pharmaceuticals and Biovie and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Reata Pharmaceuticals with a short position of Biovie. Check out your portfolio center. Please also check ongoing floating volatility patterns of Reata Pharmaceuticals and Biovie.

Diversification Opportunities for Reata Pharmaceuticals and Biovie

0.64
  Correlation Coefficient

Poor diversification

The 3 months correlation between Reata and Biovie is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding Reata Pharmaceuticals and Biovie Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biovie Inc and Reata Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Reata Pharmaceuticals are associated (or correlated) with Biovie. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biovie Inc has no effect on the direction of Reata Pharmaceuticals i.e., Reata Pharmaceuticals and Biovie go up and down completely randomly.

Pair Corralation between Reata Pharmaceuticals and Biovie

Given the investment horizon of 90 days Reata Pharmaceuticals is expected to generate 1.69 times more return on investment than Biovie. However, Reata Pharmaceuticals is 1.69 times more volatile than Biovie Inc. It trades about 0.09 of its potential returns per unit of risk. Biovie Inc is currently generating about -0.02 per unit of risk. If you would invest  3,562  in Reata Pharmaceuticals on August 30, 2024 and sell it today you would earn a total of  7,405  from holding Reata Pharmaceuticals or generate 207.89% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy31.31%
ValuesDaily Returns

Reata Pharmaceuticals  vs.  Biovie Inc

 Performance 
       Timeline  
Reata Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Reata Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Reata Pharmaceuticals is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.
Biovie Inc 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Biovie Inc are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak basic indicators, Biovie demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Reata Pharmaceuticals and Biovie Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Reata Pharmaceuticals and Biovie

The main advantage of trading using opposite Reata Pharmaceuticals and Biovie positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Reata Pharmaceuticals position performs unexpectedly, Biovie can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biovie will offset losses from the drop in Biovie's long position.
The idea behind Reata Pharmaceuticals and Biovie Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Other Complementary Tools

Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
CEOs Directory
Screen CEOs from public companies around the world
Transaction History
View history of all your transactions and understand their impact on performance
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities